tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Holding VRDN?
Track your performance easily

Viridian Therapeutics (VRDN) Ownership - Who Owns Viridian Therapeutics?

1,316 Followers

Viridian Therapeutics (VRDN) Ownership Overview

4.38%19.92%60.26%10.89%4.55%
60.26% Other Institutional Investors
10.89% ETFs
4.55% Public Companies and
Individual Investors
The ownership structure of Viridian Therapeutics (VRDN) stock is a mix of institutional, retail, and individual investors. Approximately 91.07% of the company’s stock is owned by Institutional Investors, 4.38% is owned by Insiders, and 4.55% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 30, 2024
Stephen F. Mahoney
President & Ceo,director
xxxxxxxxxxxxx
$499262
Sep 17, 2024
Fairmount Funds Management Llc
Director, >10% Owner
xxxxxxxxxxxxx
$30000000
Jan 24, 2024
Fairmount Funds Management Llc
Director, >10% Owner
xxxxxxxxxxxxx
$9999990

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$864

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,744,924Institution4.73%75,422,769
3,445,813Insider4.35%69,398,674
3,307,945Institution4.18%66,622,012
2,743,887Institution3.46%55,261,884
2,632,162Institution3.32%53,011,743
2,505,738Institution3.16%50,465,563
2,284,907Institution2.88%46,018,027
2,203,641Institution2.78%44,381,330
1,845,813Institution2.33%37,174,674
1,631,828Institution2.06%32,865,016

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,632,162Institution3.32%53,011,743
2,505,738Institution3.16%50,465,563
2,284,907Institution2.88%46,018,027
2,203,641Institution2.78%44,381,330
1,013,388Institution1.28%20,409,634
899,710Institution1.14%18,120,159
738,384Institution0.93%14,871,054
693,752Institution0.88%13,972,165
476,627Institution0.60%9,599,268
313,029Institution0.40%6,304,404

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,243,124Institution2.83%51,031,071
1,767,510Institution2.23%35,597,651
1,042,626Institution1.32%22,562,427
947,115Institution1.20%21,546,866
413,598Institution0.52%8,329,864
306,414Institution0.39%6,630,799
287,029Institution0.36%6,529,910
186,218Institution0.24%4,236,460
159,489Institution0.20%3,212,108
143,703Institution0.18%2,894,178

FAQ

Who Owns Viridian Therapeutics (VRDN)?
According to the latest TipRanks data, approximately 60.26% of the company's stock is held by institutional investors, 4.38% is held by insiders, and 4.55% is held by retail investors.
    What percentage of Viridian Therapeutics (VRDN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 60.26% of Viridian Therapeutics (VRDN) stock is held by institutional investors.
      What percentage of Viridian Therapeutics (VRDN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 4.55% of Viridian Therapeutics (VRDN) stock is held by retail investors.
        Who owns the most shares of Viridian Therapeutics (VRDN)?
        Vanguard owns the most shares of Viridian Therapeutics (VRDN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis